Home medical equipment company AdaptHealth Corp (NASDAQ:AHCO) revealed on Friday that it has entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation.
Subject to customary closing conditions, the acquisition is expected to close in December 2019.
AdaptHealth stated that the total investment, including restructuring costs until the business is fully integrated on AdaptHealth's platform in the latter half of 2020, is anticipated to be approximately USD30m.
PCS provides wound care supplies, ostomy supplies, urological supplies, incontinence supplies, diabetic care supplies and breast pumps directly to patients across the US. The company said it maintains extensive national relationships with physicians, medical facilities and customers, currently serving all 50 states. For the trailing 12 months ended 31 October 2019, it generated net revenues of about USD134m.
Under the terms of the agreement, AdaptHealth will sign a supply and distribution agreement with McKesson Corporation with respect to PCS's HME service lines.
Ocular Therapeutix prices USD475m common stock offering
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Nanomi BV to acquire ophthalmology specialist VISUfarma BV
AstraZeneca launches online platform to expand patient access to medications
Avant Technologies enters joint venture to advance stem cell-based diabetes treatments
Innovent and Ollin report progress in development of OLN324 (IBI324)
Alteogen secures European Commission approval for aflibercept biosimilar EYLUXVI
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Ascletis presents ASC30 study results at EASD Annual Meeting
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
Novo Nordisk to streamline operations and reinvest in diabetes and obesity growth